Clinical Trials List
Protocol NumberM26-120
Not yet recruiting
2026-08-01 - 2030-02-28
Phase II
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 許宇維 無
- 廖俊達 無
- 葉智華 無
- Li-Yu Lee 無
- Cheng-Lung Hsu 無
Co-Principal Investigator
- Chen-Yuan Lin 無
- Ching-Chan Lin 無
- Yu-Min Liao 無
- 陳珈妤 無
Co-Principal Investigator
- 王閔宏 無
- Tsung-Jang Yeh 無
- Jeng-Shiun Du 無
- 謝子禹 無
- 許瑞峰 無
Co-Principal Investigator
- 楊明翰 無
- 黃彥霖 無
- RUEY-LONG HONG 無
- Hsiang-Fong Kao 無
- 廖斌志 無
- YA-FANG CHEN 無
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
150 participants
